Free Access
Med Sci (Paris)
Volume 30, Novembre 2014
2e colloque de l’ITMO Santé publique – Médecine « personnalisée » et innovations biomédicales : enjeux de santé publique, économiques, éthiques et sociaux (Paris, 5 décembre 2013)
Page(s) 41 - 43
Section Session 3. La médecine personnalisée : aggravatrice ou réductrice des inégalités de santé ?
Published online 17 November 2014
  1. Hirshleifer J. The private and social value of information and the reward to incentive activity. Am Econ Rev 1971 ; 61 : 561–574. [Google Scholar]
  2. Collins F. The language of life: DNA and the revolution in personalized medicine. New York : Harpers Collins Publishers, 2010. [Google Scholar]
  3. Bardey D, De Donder P. Genetic testing with primary prevention and moral hazard. J Health Econ 2013 ; 32 : 768–779. [CrossRef] [PubMed] [Google Scholar]
  4. Hoy M, Orsi F, Eisinger F, Moatti JP. The impact of genetic testing on health care insurance. Geneva Papers on Risk and Insurance 2003 ; 28 : 203–221. [CrossRef] [Google Scholar]
  5. Barigozzi F, Henriet D. Genetic information: comparing alternative regulatory approaches when prevention matter. J Public Econ Theory 2011 ; 13 : 23–46. [CrossRef] [Google Scholar]
  6. Crainich D. Self-insurance with genetic testing tools. Working paper. LEM, 2013. [Google Scholar]
  7. Geoffard PY. Assurance maladie : la gestion du risque long. Rev Econ Polit 2000 ; 110 : 457–482. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.